Senior insider sale
EVP R&D, Chief Medical Officer at ALKERMES PLC. — senior position signals high conviction
$1.26M
36K shares
What this filing means
HOPKINSON CRAIG C. plans to sell 36K shares of ALKERMES PLC. valued at approximately $1.26M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001964306-26-000260
Officer· EVP R&D, Chief Medical Officer
Since Mar 2026
36K
Shares to sell
$1.26M
Approx. market value
9K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Exercise of employee stock options
Broker assisted cashless exercise
6/1/2026
5KVesting of performance share award
Granted as part of issuer equity compensation plan
2/5/2026
4KTotal acquired9K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2026 | Exercise of employee stock options Broker assisted cashless exercise | 5K | — |
2/5/2026 | Vesting of performance share award Granted as part of issuer equity compensation plan | 4K | — |
| Total | 9K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
9K
Market value
$300.6K
5/1/2026
—Completed
Units to sell
9K
Market value
$319.6K
4/1/2026
—Completed
Units to sell
9K
Market value
$267.5K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9K
Market value
$375.0K
6/1/2026
Total
Units
36K
Value
$1.26M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 9K | $300.6K | — | Completed |
4/1/2026 | 9K | $319.6K | — | Completed |
3/2/2026 | 9K | $267.5K | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 9K | $375.0K | NASDAQ | Planned |
| Total | 36K | $1.26M | ||